Schott Pharma AG KGaA (XTER:1SXP) Capex-to-Operating-Income : 0.59 (As of Dec. 2024)

Schott Pharma AG KGaA Capex-to-Operating-Income Chart

Schott Pharma AG KGaA Quarterly Data
	Sep20	Sep21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Capex-to-Operating-Income	Get a 7-Day Free Trial							0.51	0.69	0.61	1.19	0.59

Competitive Comparison of Schott Pharma AG KGaA's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schott Pharma AG KGaA's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's Capex-to-Operating-Income falls into.

Schott Pharma AG KGaA Capex-to-Operating-Income Calculation

Schott Pharma AG KGaA's Capex-to-Operating-Income for the fiscal year that ended in Sep. 2024 is calculated as

Schott Pharma AG KGaA's Capex-to-Operating-Income for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA  (XTER:1SXP) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Schott Pharma AG KGaA Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description